IDEXX Laboratories (IDXX) Surged Following Strong Earnings
Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tikehau Investment Management Mathieu Chabran And Antoine Flamarion | 2,804 | $1,791,448 | -53% | 2.62% |
| 2. | Bayforest Capital Theodoros Tsagaris | 538 | $343,723 | +132% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | $99,903.75 | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | $501,875.40 | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | $100,479.51 | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | $178,045.00 | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | $179,580.00 | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $647.33 | 2,187 | $1,415,700.21 | 262 | 2025-08-22 | Filing | |
| $649.85 | 88 | $57,116.68 | 11,287 | 2025-08-12 | Filing | |
| $649.99 | 318 | $206,696.82 | 11,375 | 2025-08-12 | Filing | |
| $656.53 | 1,200 | $787,840.20 | 16,807 | 2025-08-11 | Filing | |
| $651.60 | 5,450 | $3,551,220.00 | 6,156 | 2025-08-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 296,530 | $189,450,052 | 2.57% | |
| 2. | 206,516 | $131,941,007 | 0.19% | |
| 3. | 200,480 | $128,084,667 | 0.07% | |
| 4. | 147,384 | $94,162,164 | 0.28% | |
| 5. | 141,276 | $90,259,824 | 6.52% |
News See All
12 Best Healthcare Stocks to Buy and Hold for 5 Years
Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after contacting carriers via phone and email. This can be changed by Dr.
Piper Sandler Raises IDEXX Laboratories (IDXX) PT to $700, Cites Strong Q2 Results
IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best performing S&P 500 stocks to buy now.
11 Best Performing S&P 500 Stocks to Buy Now
On August 7, Jonathan Krinsky, BTIG technician, joined CNBC's 'Closing Bell' to discuss his thoughts on the current market standing.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2025 Earnings Conference Call. As a reminder, today's conference is being recorded.
Excellent Execution Drove IDEXX Laboratories (IDXX) Shares Amid Macro Challenges
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Leerink Raises PT on IDEXX Laboratories (IDXX) Stock
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the Best Stocks to Buy According to Brasada Capital Management.
10 Best Stocks to Buy According to Brasada Capital Management
Brasada Capital Management is a leading hedge fund with its headquarters in Houston, Texas. It was established in June 2008 by industry veterans, Mark Edward McMeans and James Gabriel Birdsall.
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.